- 2023 - 2028 Development and application of ECM information analysis using decellularized matrix and proteomics.
- 2023 - 2028 領域研究「細胞外情報を統御するマルチモーダルECM」の統括と運営
- 2023 - 2027 CYLD依存的形質転換が導く分子標的薬感受性向上を軸とした治療不応癌患者への治療提供
- 2022 - 2026 Molecular basis of blood biomarkers inducing fundamental innovation in glioblastoma medicine
- 2022 - 2026 Identification of macrotranscytosis based on clarification of the molecular mechanism of transport of tissue barrier penetrating peptides
- 2022 - 2025 Development of high-throughput single-cell proteomics system
- 2021 - 2024 New molecular mechanisms for membrane-mediated transcellular transport across the blood brain barrier
- 2018 - 2022 癌の生命予後規定因子CYLDの分子診断を突破口とした従来にない分子標的治療の確立
- 2019 - 2021 Approach to regulatory mechanism of copy number variation the gene amplified.
- 2018 - 2021 Diagnosis of Alzheimer's disease by plasma
- 2017 - 2019 Identification of diagnostic biomarker for glioblasotma with innovative proteomics
- 2016 - 2019 Regulation mechanism of cell senescence by orphan transporter
- 2016 - 2018 Elucidation of pemeable mechanism of new intestinal permeable peptide
- 2016 - 2018 Exploration of blood biomarker for glioblastoma
- 2015 - 2017 Identification of the biomarker in cerebrospinal fluid of glioblastoma by innovative proteomics
- 2014 - 2017 Study on biomarkers of Alzheimer's disease for personalized medicine
- 2014 - 2017 Study for Pathogenesis of Cerebral Creatine Deficiency Syndromes
- 2014 - 2017 Mechanism of cellular localization of mutated creatine transporter toward therapy for creatine deficiency syndromes
- 2014 - 2016 Ultra-deep quantitative proteomics with RT-normalized peptide database
- 2010 - 2016 Establishment of Integrative Multi-level Systems Biology and its Applications
- 2011 - 2013 Global and target-oriented proteomic analysis in the postmortem brains from patients with schizophrenia
- 2010 - 2010 小分子生体内挙動を制御する因子の組織・臓器階層における網羅的解析
Show all